Roche May Sell Drugs Directly in US to Bypass Middlemen (3)

Roche Holding AG is weighing direct-to-patient drug sales in the US, bypassing the middleman for its pricey medicines for multiple sclerosis, eye disease and cancer.

The Swiss drugmaker has discussed direct-to-patient sales with the US government, Chief Executive Officer Thomas Schinecker said on Thursday as the company reported earnings. The move would bring down costs “quite quickly,” he said.

A push into direct selling would echo recent moves by Pfizer Inc., Eli Lilly & Co. and Novo Nordisk A/S, which have all begun selling medicines via telehealth.

Read More: Pfizer Follows Lilly With Site Selling Directly to Patients

“Something ...